Barely Significant
← all excerpts

Permutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHF.

Clin Res Cardiol · 2011 · PMC3167045 · PMID 21416190

1
hedged sentence
closest p
boldest claim

The sentences

a positive trendno p-value reported
Results for 3 of these 36 comparisons (one permuted dose group compared against placebo for 3 of the 9 endpoints), and the number of endpoint comparisons out of 9 with a positive trend for that dose group, are shown for the 10 illustrative permutation samples in Table 3 .

also in 11,005 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.